Home / Treatments / Fusion
Fusion denials: what the review data shows
Independent reviewers have decided 246 published cases where an insurer denied Fusion — and they overturned the insurer 28% of the time. A denial for Fusion is a starting position, not a final answer.
Published decisions
246
2001–2026
Overturned
28%
69 denials reversed
Conditions behind fusion denials
What insurers denied — and how those fights ended.
| Category | Decisions | Overturned |
|---|---|---|
| Vertebral Disc Prob | 98 | 24.5% |
| Back Pain | 83 | 25.3% |
| Joint Problem | 11 | 27.3% |
| Joint Problem Pain | 6 | 83.3% |
| Neck Problem | 4 | 50% |
| Neck Problem Pain | 3 | 33.3% |
| Sciatica | 3 | 0% |
What the insurer actually argued
Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
| Reason given | Decisions | Overturned |
|---|---|---|
Medical Necessity The plan said the care wasn’t medically necessary. The most common fight, and the most winnable. | 197 | 26.4% |
Experimental/Investigational The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument. | 47 | 34% |
Typical time to a decision
7 days
Most land between 4 and 16 days
Handled as urgent
62.2%
Expedited when a delay would cause harm
Recent direction
Falling
41.9% → 34.4% overturned, last three years
What the reviewers wrote
Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.
Where the denial was overturned
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for L4-L5 minimally invasive intradiscal lumbar interbody fusion (MIS-IntraLIF) with L4-5 facetectomies and discectomy, intrafacet and interbody autograft-allograft arthrodesis, and placement of interbody mechanical device. Treatment of low back pain with lumbar fusion, in the absence of instability, trauma, tumor, or fracture is and has been a very common practice although controversy remains in terms of its efficacy, safety, and cost effectiveness. The main question explored in current medical literature is whether lumbar spinal fusion surgery is better than nonoperative management in patients who have already tried and failed long-term exhaustive conservative management.
Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for two level lumbar fusion, with or without cage. Treatment of low back pain with lumbar fusion, in the absence of instability, trauma, tumor, or fracture is and has been a very common practice but remains controversial in terms of its efficacy, safety, and cost effectiveness versus nonsurgical strategies. In a meta-analysis, Xu and colleagues concluded that spinal fusion was not better than nonoperative treatment for degenerative disc disease with regard to pain and disability and that careful evaluation of the risks of reoperation and the complications of lumbar fusion surgery were needed in such decisions. Yavin and colleagues suggest that lumbar fusion is most efficacious for patients with spondylolisthesis, a condition that this patient does not have.
Where the denial was upheld
Worth reading too — these show what an appeal has to overcome.
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for posterior sacroiliac joint fusion procedure. Researchers explain, “The sacroiliac joint may be a primary source of pain in patients complaining of low back and/or buttock pain. Nonsurgical treatment of sacroiliac joint pain typically includes structured core and pelvic muscle flexibility and strengthening; pharmaceutical management through oral and injectable medication; and ablation procedures. For patients who do not improve with comprehensive, nonoperative treatment, surgical fusion of the sacroiliac joint is an option with overall good reported outcomes and high patient satisfaction. Minimally invasive surgery (MIS) approaches have been shown to have lower morbidity and earlier recovery than traditional open approaches.
Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for (1) L5-S1 anterior lumbar interbody fusion surgery and (2) L4-L5 fusion surgery. Medical literature state, “A trial of conservative therapy may be considered for patients with low-grade spondylolisthesis presenting with radiculopathy and/or pseudoclaudication. These options may include physical therapy, epidural steroid injection, and pain medications. If unresolved, surgical options may include decompression alone or decompression and fusion.” Researchers state, “Patients with symptomatic lumbar spondylolisthesis may first be treated with conservative management strategies including, but not limited to, non-narcotic and narcotic pain medications, epidural steroid injections, transforaminal injections, and physical therapy.
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.
How to use this in your appeal
These are outcomes from California’s external review program — an independent physician panel that binds the insurer. Every state has an equivalent process, and internal appeals succeed even more often. Cite the outcome record for Fusionwhen you appeal: reviewers routinely find that denials like yours didn’t hold up.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY
Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.